share_log

太龙药业(600222.SH):公司产品哈伯因适用于良性记忆障碍

Tailong Pharmaceutical (600222.SH): The company's product Habain is suitable for benign memory impairment

Gelonghui Finance ·  Dec 18, 2023 06:33

Gelonghui, December 18|Tailong Pharmaceutical (600222.SH) stated on the investor interactive platform that the company's product Habain (generic name: Huperzine tablets) is suitable for benign memory impairment, enhances patients' ability to point to memory, associative learning, image recall, meaningless graphics, and recall portraits, etc., and also has an effect on improving memory impairment caused by dementia patients and organic brain lesions. Please use it under the guidance of a pharmacist or refer to the drug instructions.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment